SUBPART H—Payment for End-Stage Renal Disease (ESRD) Services and Organ Procurement Costs (§413.170 to §413.241)
- 413.170—Scope.
- 413.171—Definitions.
- 413.172—Principles of prospective payment.
- 413.174—Prospective rates for hospital-based and independent ESRD facilities.
- 413.176—Amount of payments.
- 413.178—Bad debts.
- 413.180—Procedures for requesting exceptions to payment rates.
- 413.182—Criteria for approval of exception requests.
- 413.184—Payment exception: Pediatric patient mix.
- 413.186—Payment exception: Self-dialysis training costs in pediatric facilities.
- 413.194—Appeals.
- 413.195—Limitation on Review.
- 413.196—Notification of changes in rate-setting methodologies and payment rates.
- 413.198—Recordkeeping and cost reporting requirements for outpatient maintenance dialysis.
- 413.200—Payment of independent organ procurement organizations and histocompatibility laboratories.
- 413.202—Organ procurement organization (OPO) cost for kidneys sent to foreign countries or transplanted in patients other than Medicare beneficiaries.
- 413.203—Transplant center costs for organs sent to foreign countries or transplanted in patients other than Medicare beneficiaries.
- 413.210—Conditions for payment under the end-stage renal disease (ESRD) prospective payment system.
- 413.215—Basis of payment.
- 413.217—Items and services included in the ESRD prospective payment system.
- 413.220—Methodology for calculating the per-treatment base rate under the ESRD prospective payment system effective January 1, 2011.
- 413.230—Determining the per treatment payment amount.
- 413.231—Adjustment for wages.
- 413.232—Low-volume adjustment.
- 413.235—Patient-level adjustments.
- 413.237—Outliers.
- 413.239—Transition period.
- 413.241—Pharmacy arrangements.